×
This post has expired! It was posted more than 90 days ago.
<- Back

149265 - The National Obesity Forum 2019

Speciality Classification
General Practice ( GP ) / Family Medicine
Location
Online
Delivery
Online
Duration
2 hours

The National Obesity Tour 2019 is a succinct evening seminar that will be addressing the prevalent epidemic of obesity in Australia. This seminar will cover the neurohormonal aspects of weight regulation, provide an understanding of the scientific basis for the naltrexone bupropion combination for weight loss and provide practical advice on the quality use of medicines for the treatment of obesity- including patient selection criteria. 
The event will be held in Perth, Adelaide, Sydney, Melbourne and Brisbane across different dates.

Relevance to General Practice

Obesity is highly relevant to both general practice and the community as excess weight, especially obesity, is a major risk factor for cardiovascular disease, Type 2 diabetes, some musculoskeletal conditions and some cancers (1). Obesity is the second highest contributor to burden of disease and further to this in 2014-15, 63.4% of Australian adults were overweight or obese which is an increase since 1995 (56.3%) and even more worrying is that around 27.4% of children aged 5 -17 years old were overweight or obese (2). A pilot study led by Dr Liz Sturgiss from the ANU Medical school found that GPs were well placed on the health frontline to help patients manage their weight, but they did not have the confidence to do so effectively (3). 1. AIHW (2017) - http://www.aihw.gov.au/overweight-and-obesity/ 2. ABS (2016) - http://www.abs.gov.au/ausstats/abs(at).nsf/mf/4364.0.55.001 3. ANU (2016) - http://www.anu.edu.au/news/all-news/gps-can-and-must-do-more-to-tackle-obesity-crisis

Lea rning outcomes
  • Improve understanding of the neurohormonal drivers of obesity-related behaviours and weight regulation
  • Summarise practical advice on evidence based use of pharmacotherapy, in conjunction with non-drug strategies, currently recommended for treatment of obesity
  • Develop practical understanding of the scientific basis for the use of naltrexone bupropion combination for weight loss
  • Delivery
    Title
    149265 - The National Obesity Forum 2019
    Location
    Provider Type
    Education Provider
    Duration
    2 hours
    Start Date
    18-Feb-2019
    End Date
    24-Dec-2019
    CPD Points
    2 hours
    Price
    Free
    Location
    Online
    HealthcareLink